Annual CFF
$149.30 M
+$1.90 B+108.54%
31 December 2023
Summary:
Biogen annual cash flow from financing activities is currently $149.30 million, with the most recent change of +$1.90 billion (+108.54%) on 31 December 2023. During the last 3 years, it has risen by +$5.42 billion (+102.83%). BIIB annual CFF is now -80.93% below its all-time high of $783.10 million, reached on 31 December 2015.BIIB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$6.60 M
+$238.60 M+97.31%
30 September 2024
Summary:
Biogen quarterly cash flow from financing activities is currently -$6.60 million, with the most recent change of +$238.60 million (+97.31%) on 30 September 2024. Over the past year, it has dropped by -$855.20 million (-100.78%). BIIB quarterly CFF is now -100.23% below its all-time high of $2.91 billion, reached on 30 September 2015.BIIB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$1.34 B
-$855.20 M-177.32%
30 September 2024
Summary:
Biogen TTM cash flow from financing activities is currently -$1.34 billion, with the most recent change of -$855.20 million (-177.32%) on 30 September 2024. Over the past year, it has dropped by -$2.13 billion (-269.73%). BIIB TTM CFF is now -154.12% below its all-time high of $2.47 billion, reached on 30 September 2015.BIIB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIIB Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +108.5% | -100.8% | -269.7% |
| 3 y3 years | +102.8% | +99.1% | +46.4% |
| 5 y5 years | +103.3% | +99.0% | +74.2% |
BIIB Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +102.8% | -100.8% | +99.5% | -269.7% | +46.4% |
| 5 y | 5 years | at high | +102.5% | -100.8% | +99.7% | -269.7% | +82.0% |
| alltime | all time | -80.9% | +102.5% | -100.2% | +99.8% | -154.1% | +82.0% |
Biogen Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$6.60 M(-97.3%) | -$1.34 B(+177.3%) |
| June 2024 | - | -$245.20 M(-44.2%) | -$482.30 M(+95.3%) |
| Mar 2024 | - | -$439.60 M(-32.0%) | -$246.90 M(-265.4%) |
| Dec 2023 | $149.30 M(-108.5%) | -$646.10 M(-176.1%) | $149.30 M(-81.1%) |
| Sept 2023 | - | $848.60 M(-8759.2%) | $788.00 M(-160.0%) |
| June 2023 | - | -$9.80 M(-77.4%) | -$1.31 B(-26.0%) |
| Mar 2023 | - | -$43.40 M(+486.5%) | -$1.77 B(+1.5%) |
| Dec 2022 | -$1.75 B(-16.2%) | -$7.40 M(-99.4%) | -$1.75 B(+1.0%) |
| Sept 2022 | - | -$1.25 B(+165.5%) | -$1.73 B(+41.3%) |
| June 2022 | - | -$471.50 M(+2757.6%) | -$1.22 B(-7.1%) |
| Mar 2022 | - | -$16.50 M(-268.4%) | -$1.32 B(-36.8%) |
| Dec 2021 | -$2.09 B(-60.4%) | $9.80 M(-101.3%) | -$2.09 B(-16.5%) |
| Sept 2021 | - | -$746.50 M(+32.2%) | -$2.50 B(-18.5%) |
| June 2021 | - | -$564.50 M(-28.1%) | -$3.06 B(-19.6%) |
| Mar 2021 | - | -$785.00 M(+95.7%) | -$3.81 B(-27.7%) |
| Dec 2020 | -$5.27 B(-10.0%) | -$401.10 M(-69.4%) | -$5.27 B(-24.5%) |
| Sept 2020 | - | -$1.31 B(-0.0%) | -$6.99 B(+9.8%) |
| June 2020 | - | -$1.31 B(-41.5%) | -$6.36 B(-14.3%) |
| Mar 2020 | - | -$2.25 B(+6.1%) | -$7.43 B(+26.7%) |
| Dec 2019 | -$5.86 B(+31.0%) | -$2.12 B(+207.2%) | -$5.86 B(+13.1%) |
| Sept 2019 | - | -$689.00 M(-71.0%) | -$5.18 B(+16.0%) |
| June 2019 | - | -$2.38 B(+249.7%) | -$4.47 B(-8.5%) |
| Mar 2019 | - | -$679.30 M(-52.7%) | -$4.88 B(+9.2%) |
| Dec 2018 | -$4.47 B(+87.9%) | -$1.44 B(-5825.1%) | -$4.47 B(+19.5%) |
| Sept 2018 | - | $25.10 M(-100.9%) | -$3.74 B(-1.2%) |
| June 2018 | - | -$2.79 B(+939.3%) | -$3.79 B(+116.8%) |
| Mar 2018 | - | -$268.60 M(-62.1%) | -$1.75 B(-26.6%) |
| Dec 2017 | -$2.38 B(+126.1%) | -$708.10 M(+3531.3%) | -$2.38 B(-0.8%) |
| Sept 2017 | - | -$19.50 M(-97.4%) | -$2.40 B(-10.6%) |
| June 2017 | - | -$751.00 M(-16.7%) | -$2.68 B(+37.7%) |
| Mar 2017 | - | -$901.40 M(+24.1%) | -$1.95 B(+85.2%) |
| Dec 2016 | -$1.05 B(-234.4%) | -$726.50 M(+138.0%) | -$1.05 B(-58.4%) |
| Sept 2016 | - | -$305.30 M(+1832.3%) | -$2.53 B(-469.0%) |
| June 2016 | - | -$15.80 M(+216.0%) | $685.10 M(-1.7%) |
| Mar 2016 | - | -$5.00 M(-99.8%) | $697.30 M(-11.0%) |
| Dec 2015 | $783.10 M(-203.6%) | -$2.20 B(-175.7%) | $783.10 M(-68.3%) |
| Sept 2015 | - | $2.91 B(<-9900.0%) | $2.47 B(-624.5%) |
| June 2015 | - | -$3.60 M(-104.5%) | -$471.21 M(-40.4%) |
| Mar 2015 | - | $80.80 M(-115.7%) | -$789.98 M(+4.5%) |
| Dec 2014 | -$755.90 M(+5.5%) | -$513.29 M(+1361.4%) | -$755.90 M(+226.7%) |
| Sept 2014 | - | -$35.12 M(-89.1%) | -$231.40 M(-55.1%) |
| June 2014 | - | -$322.36 M(-380.6%) | -$514.80 M(+41.7%) |
| Mar 2014 | - | $114.88 M(+924.8%) | -$363.20 M(-49.3%) |
| Dec 2013 | -$716.50 M(-18.3%) | $11.21 M(-103.5%) | -$716.50 M(-3.6%) |
| Sept 2013 | - | -$318.52 M(+86.5%) | -$743.23 M(+64.1%) |
| June 2013 | - | -$170.76 M(-28.4%) | -$452.96 M(-35.3%) |
| Mar 2013 | - | -$238.42 M(+1435.8%) | -$699.64 M(-20.3%) |
| Dec 2012 | -$877.48 M(+174.3%) | -$15.52 M(-45.0%) | -$877.48 M(-12.7%) |
| Sept 2012 | - | -$28.25 M(-93.2%) | -$1.00 B(-6.6%) |
| June 2012 | - | -$417.44 M(+0.3%) | -$1.08 B(+69.0%) |
| Mar 2012 | - | -$416.26 M(+191.5%) | -$636.29 M(+98.9%) |
| Dec 2011 | -$319.86 M(-82.1%) | -$142.81 M(+44.1%) | -$319.86 M(-754.5%) |
| Sept 2011 | - | -$99.13 M(-552.5%) | $48.87 M(-115.6%) |
| June 2011 | - | $21.91 M(-121.9%) | -$313.26 M(-77.0%) |
| Mar 2011 | - | -$99.83 M(-144.2%) | -$1.36 B(-23.7%) |
| Dec 2010 | -$1.78 B(+146.5%) | $225.93 M(-149.0%) | -$1.78 B(-33.3%) |
| Sept 2010 | - | -$461.26 M(-55.0%) | -$2.68 B(+21.2%) |
| June 2010 | - | -$1.03 B(+96.0%) | -$2.21 B(+87.2%) |
| Mar 2010 | - | -$523.46 M(-21.5%) | -$1.18 B(+63.0%) |
| Dec 2009 | -$724.15 M(-41.3%) | -$666.76 M(<-9900.0%) | -$724.15 M(+86.1%) |
| Sept 2009 | - | $6.38 M(+102.6%) | -$389.19 M(+49.3%) |
| June 2009 | - | $3.15 M(-104.7%) | -$260.74 M(-49.3%) |
| Mar 2009 | - | -$66.93 M(-79.8%) | -$514.02 M(-58.4%) |
| Dec 2008 | -$1.23 B(+67.9%) | -$331.79 M(-346.1%) | -$1.23 B(+201.7%) |
| Sept 2008 | - | $134.83 M(-153.9%) | -$409.18 M(-78.0%) |
| June 2008 | - | -$250.13 M(-68.2%) | -$1.86 B(+20.3%) |
| Mar 2008 | - | -$787.53 M(-259.5%) | -$1.55 B(+110.4%) |
| Dec 2007 | -$735.22 M | $493.65 M(-137.5%) | -$735.22 M(-36.6%) |
| Sept 2007 | - | -$1.32 B(-2145.7%) | -$1.16 B(+654.0%) |
| June 2007 | - | $64.41 M(+164.0%) | -$153.89 M(-25.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | $24.40 M(-64.4%) | -$207.66 M(+39.9%) |
| Dec 2006 | -$148.41 M(-84.4%) | $68.57 M(-122.0%) | -$148.41 M(-0.5%) |
| Sept 2006 | - | -$311.27 M(-3027.1%) | -$149.10 M(-182.2%) |
| June 2006 | - | $10.63 M(-87.3%) | $181.46 M(-125.1%) |
| Mar 2006 | - | $83.66 M(+23.2%) | -$723.69 M(-23.7%) |
| Dec 2005 | -$948.52 M(+110.3%) | $67.88 M(+251.9%) | -$948.52 M(-1.9%) |
| Sept 2005 | - | $19.29 M(-102.2%) | -$967.10 M(-25.5%) |
| June 2005 | - | -$894.52 M(+533.6%) | -$1.30 B(+87.9%) |
| Mar 2005 | - | -$141.18 M(-386.3%) | -$690.45 M(+53.1%) |
| Dec 2004 | -$450.96 M(-981.0%) | $49.31 M(-115.9%) | -$450.96 M(-2.2%) |
| Sept 2004 | - | -$310.92 M(+8.1%) | -$461.00 M(+212.9%) |
| June 2004 | - | -$287.65 M(-392.6%) | -$147.34 M(-201.5%) |
| Mar 2004 | - | $98.31 M(+150.4%) | $145.22 M(+183.7%) |
| Dec 2003 | $51.19 M(-91.2%) | $39.26 M(+1334.6%) | $51.19 M(-91.3%) |
| Sept 2003 | - | $2.74 M(-44.2%) | $585.67 M(+0.0%) |
| June 2003 | - | $4.91 M(+14.7%) | $585.58 M(-0.2%) |
| Mar 2003 | - | $4.28 M(-99.3%) | $586.99 M(+0.5%) |
| Dec 2002 | $584.06 M(-1104.3%) | $573.75 M(>+9900.0%) | $584.06 M(-9360.6%) |
| Sept 2002 | - | $2.65 M(-58.0%) | -$6.31 M(-85.6%) |
| June 2002 | - | $6.31 M(+368.1%) | -$43.80 M(-28.6%) |
| Mar 2002 | - | $1.35 M(-108.1%) | -$61.33 M(+5.5%) |
| Dec 2001 | -$58.16 M(-78.4%) | -$16.62 M(-52.3%) | -$58.16 M(-58.1%) |
| Sept 2001 | - | -$34.84 M(+210.5%) | -$138.89 M(+15.5%) |
| June 2001 | - | -$11.22 M(-347.9%) | -$120.27 M(-40.6%) |
| Mar 2001 | - | $4.53 M(-104.6%) | -$202.44 M(-24.8%) |
| Dec 2000 | -$269.14 M(+120.6%) | -$97.36 M(+500.3%) | -$269.14 M(-20.4%) |
| Sept 2000 | - | -$16.22 M(-82.6%) | -$338.11 M(+8.3%) |
| June 2000 | - | -$93.39 M(+50.2%) | -$312.19 M(+18.7%) |
| Mar 2000 | - | -$62.17 M(-62.6%) | -$262.90 M(+115.4%) |
| Dec 1999 | -$122.03 M(+125.7%) | -$166.33 M(-1814.7%) | -$122.03 M(-625.5%) |
| Sept 1999 | - | $9.70 M(-122.0%) | $23.22 M(+182.4%) |
| June 1999 | - | -$44.10 M(-156.0%) | $8.22 M(-77.9%) |
| Mar 1999 | - | $78.70 M(-473.4%) | $37.22 M(-168.8%) |
| Dec 1998 | -$54.08 M(-182.1%) | -$21.08 M(+297.7%) | -$54.08 M(-721.8%) |
| Sept 1998 | - | -$5.30 M(-64.9%) | $8.70 M(-37.9%) |
| June 1998 | - | -$15.10 M(+19.8%) | $14.00 M(+41.4%) |
| Mar 1998 | - | -$12.60 M(-130.2%) | $9.90 M(-85.0%) |
| Dec 1997 | $65.90 M(+27.3%) | $41.70 M(>+9900.0%) | $65.90 M(+64.4%) |
| Sept 1997 | - | $0.00(-100.0%) | $40.07 M(-21.8%) |
| June 1997 | - | -$19.20 M(-144.2%) | $51.27 M(-38.7%) |
| Mar 1997 | - | $43.40 M(+173.4%) | $83.67 M(+61.6%) |
| Dec 1996 | $51.77 M(-30.0%) | $15.87 M(+41.7%) | $51.77 M(-16.0%) |
| Sept 1996 | - | $11.20 M(-15.2%) | $61.65 M(-13.0%) |
| June 1996 | - | $13.20 M(+14.8%) | $70.85 M(+18.6%) |
| Mar 1996 | - | $11.50 M(-55.3%) | $59.75 M(-19.2%) |
| Dec 1995 | $73.95 M(+375.7%) | $25.75 M(+26.2%) | $73.95 M(+50.8%) |
| Sept 1995 | - | $20.40 M(+871.4%) | $49.05 M(+46.6%) |
| June 1995 | - | $2.10 M(-91.8%) | $33.45 M(-14.3%) |
| Mar 1995 | - | $25.70 M(+2941.4%) | $39.05 M(+151.2%) |
| Dec 1994 | $15.54 M(+99.3%) | $845.00 K(-82.4%) | $15.54 M(-15.5%) |
| Sept 1994 | - | $4.80 M(-37.7%) | $18.40 M(+21.9%) |
| June 1994 | - | $7.70 M(+250.0%) | $15.10 M(+69.7%) |
| Mar 1994 | - | $2.20 M(-40.5%) | $8.90 M(+14.1%) |
| Dec 1993 | $7.80 M(-22.0%) | $3.70 M(+146.7%) | $7.80 M(-28.4%) |
| Sept 1993 | - | $1.50 M(0.0%) | $10.90 M(-5.2%) |
| June 1993 | - | $1.50 M(+36.4%) | $11.50 M(+8.5%) |
| Mar 1993 | - | $1.10 M(-83.8%) | $10.60 M(+6.0%) |
| Dec 1992 | $10.00 M(-88.4%) | $6.80 M(+223.8%) | $10.00 M(-88.7%) |
| Sept 1992 | - | $2.10 M(+250.0%) | $88.30 M(-0.5%) |
| June 1992 | - | $600.00 K(+20.0%) | $88.70 M(+1.1%) |
| Mar 1992 | - | $500.00 K(-99.4%) | $87.70 M(+1.4%) |
| Dec 1991 | $86.50 M(-4905.6%) | $85.10 M(+3304.0%) | $86.50 M(>+9900.0%) |
| Sept 1991 | - | $2.50 M(-725.0%) | $100.00 K(-105.3%) |
| June 1991 | - | -$400.00 K(-42.9%) | -$1.90 M(+18.8%) |
| Mar 1991 | - | -$700.00 K(-46.2%) | -$1.60 M(-11.1%) |
| Dec 1990 | -$1.80 M(-102.8%) | -$1.30 M(-360.0%) | -$1.80 M(+260.0%) |
| Sept 1990 | - | $500.00 K(-600.0%) | -$500.00 K(-50.0%) |
| June 1990 | - | -$100.00 K(-88.9%) | -$1.00 M(+11.1%) |
| Mar 1990 | - | -$900.00 K | -$900.00 K |
| Dec 1989 | $64.50 M | - | - |
FAQ
- What is Biogen annual cash flow from financing activities?
- What is the all time high annual CFF for Biogen?
- What is Biogen annual CFF year-on-year change?
- What is Biogen quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Biogen?
- What is Biogen quarterly CFF year-on-year change?
- What is Biogen TTM cash flow from financing activities?
- What is the all time high TTM CFF for Biogen?
- What is Biogen TTM CFF year-on-year change?
What is Biogen annual cash flow from financing activities?
The current annual CFF of BIIB is $149.30 M
What is the all time high annual CFF for Biogen?
Biogen all-time high annual cash flow from financing activities is $783.10 M
What is Biogen annual CFF year-on-year change?
Over the past year, BIIB annual cash flow from financing activities has changed by +$1.90 B (+108.54%)
What is Biogen quarterly cash flow from financing activities?
The current quarterly CFF of BIIB is -$6.60 M
What is the all time high quarterly CFF for Biogen?
Biogen all-time high quarterly cash flow from financing activities is $2.91 B
What is Biogen quarterly CFF year-on-year change?
Over the past year, BIIB quarterly cash flow from financing activities has changed by -$855.20 M (-100.78%)
What is Biogen TTM cash flow from financing activities?
The current TTM CFF of BIIB is -$1.34 B
What is the all time high TTM CFF for Biogen?
Biogen all-time high TTM cash flow from financing activities is $2.47 B
What is Biogen TTM CFF year-on-year change?
Over the past year, BIIB TTM cash flow from financing activities has changed by -$2.13 B (-269.73%)